会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明授权
    • 5-lipoxygenase inhibitors
    • 5-脂氧合酶抑制剂
    • US5883106A
    • 1999-03-16
    • US020014
    • 1998-02-06
    • Rodney W. StevensTakashi ManoKazunari NakaoYoshiyuki Okumura
    • Rodney W. StevensTakashi ManoKazunari NakaoYoshiyuki Okumura
    • C07D231/12C07D309/08C07D521/00A61K31/085A61K31/11A61K31/15A61K31/19A61K31/34A61K31/40A61K31/44C07C69/76C07C233/28C07C233/64C07C235/40C07C323/23C07D207/30C07D249/04C07D309/32
    • C07D231/12C07D233/56C07D249/08C07D309/08
    • Novel compounds having the ability to inhibit 5-lipoxygenase enzyme and having the following formula I: ##STR1## and the pharmaceutically acceptable salts thereof, wherein Ar.sup.1 is a heterocyclic moiety which is selected from imidazolyl, pyrrolyl, pyrazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, indolyl, indazolyl and benzimidazolyl, which is bonded to X.sup.1 through a ring nitrogen atom, and which may be optionally substituted with one or two substituents selected from halo, hydroxy, cyano, amino, and C.sub.1-4 alkyl; X.sup.1 is a direct bond or C.sub.1-4 alkylene; Ar.sup.2 is phenylene optionally substituted with halo, hydroxy, cyano, and amino X.sup.2 is --A--X-- or --X--A-- wherein A is a direct bond or C.sub.1-4 alkylene and X is oxy, thio, sulfinyl or sulfonyl; Ar.sup.3 is phenylene, pyridylene, thienylene, furylene, oxazolylene or thiazolylene optionally substituted with one or two substituents selected from halo, hydroxy, cyano, amino and C.sub.1-4 alkyl; R.sup.1 and R.sup.2 are each C.sub.1-4 alkyl, or together they form a group of formula --D.sup.1 --Z--D.sup.2 -- which together with the carbon atom to which it is attached defines a ring having 3 to 8 atoms, wherein D.sup.1 and D.sup.2 are C.sub.1-4 alkylene and Z is a direct bond or oxy, thio, sulfinyl, sulfonyl, or vinylene, and D.sup.1 and D.sup.2 may be substituted by C.sub.1-3 alkyl; and Y is CONR.sup.3 R.sup.4, CN, C(R.sup.3).dbd.N--OR.sup.4, COOR.sup.3, COR.sup.3 or CSNR.sup.3 R.sup.4, wherein R.sup.3 and R.sup.4 are each H or C.sub.1-4 alkyl. These compounds are useful in the treatment or alleviation of inflammatory diseases, allergy and cardiovascular diseases in mammals and as the active ingredient in pharmaceutical compositions for treating such conditions.
    • 具有抑制5-脂肪氧合酶并具有下式I的能力的新型化合物:其中Ar1是选自咪唑基,吡咯基,吡唑基,1,2,3或3位的杂环部分 三唑基,1,2,4-三唑基,吲哚基,吲唑基和苯并咪唑基,其通过环氮原子与X1键合,并且其可任选被一个或两个选自卤素,羟基,氰基,氨基和 C 1-4烷基; X1是直接键或C1-4亚烷基; Ar 2是任选被卤素,羟基,氰基取代的亚苯基,氨基X2是-A-X-或-X-A-,其中A是直接键或C 1-4亚烷基,X是氧基,硫代,亚磺酰基或磺酰基; Ar 3是任选被一个或两个选自卤素,羟基,氰基,氨基和C 1-4烷基的取代基取代的亚苯基,亚吡啶基,亚噻吩基,呋喃基,恶唑基或噻唑基; R1和R2各自为C1-4烷基,或者它们一起形成式-D1-Z-D2-的基团,与其所连接的碳原子一起形成具有3至8个原子的环,其中D1和D2是 C 1-4亚烷基,Z是直接键或氧基,硫基,亚磺酰基,磺酰基或亚乙烯基,D1和D2可以被C 1-3烷基取代; 并且Y是CONR 3 R 4,CN,C(R 3)= N-OR 4,COOR 3,COR 3或CSNR 3 R 4,其中R 3和R 4各自为H或C 1-4烷基。 这些化合物可用于治疗或缓解哺乳动物的炎性疾病,变态反应和心血管疾病,并用作治疗这些病症的药物组合物中的活性成分。